160 related articles for article (PubMed ID: 38465855)
21. Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer.
Schointuch MN; Gilliam TP; Stine JE; Han X; Zhou C; Gehrig PA; Kim K; Bae-Jump VL
Gynecol Oncol; 2014 Aug; 134(2):346-55. PubMed ID: 24880141
[TBL] [Abstract][Full Text] [Related]
22. Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer.
Xu G; Zhao Z; Wysham WZ; Roque DR; Fang Z; Sun W; Yin Y; Deng B; Shen X; Zhou C; Bae-Jump V
Front Oncol; 2023; 13():1219923. PubMed ID: 37601677
[TBL] [Abstract][Full Text] [Related]
23. Sorafenib targets and inhibits the oncogenic properties of endometrial cancer stem cells via the RAF/ERK pathway.
Takao T; Masuda H; Kajitani T; Miki F; Miyazaki K; Yoshimasa Y; Katakura S; Tomisato S; Uchida S; Uchida H; Tanaka M; Maruyama T
Stem Cell Res Ther; 2022 Jun; 13(1):225. PubMed ID: 35659728
[TBL] [Abstract][Full Text] [Related]
24. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
West L; Yin Y; Pierce SR; Fang Z; Fan Y; Sun W; Tucker K; Staley A; Zhou C; Bae-Jump V
Am J Cancer Res; 2020; 10(12):4450-4463. PubMed ID: 33415010
[TBL] [Abstract][Full Text] [Related]
26. SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models.
Zhao X; Kong W; Tucker K; Staley A; Fan Y; Sun W; Yin Y; Huang Y; Fang Z; Wang J; Sen S; Dugar S; Zhou C; Bae-Jump VL
Am J Transl Res; 2020; 12(8):4264-4276. PubMed ID: 32913503
[TBL] [Abstract][Full Text] [Related]
27. Terpenoids from Zingiber officinale (Ginger) induce apoptosis in endometrial cancer cells through the activation of p53.
Liu Y; Whelan RJ; Pattnaik BR; Ludwig K; Subudhi E; Rowland H; Claussen N; Zucker N; Uppal S; Kushner DM; Felder M; Patankar MS; Kapur A
PLoS One; 2012; 7(12):e53178. PubMed ID: 23300887
[TBL] [Abstract][Full Text] [Related]
28. Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-β signaling pathway.
Bokhari AA; Baker TM; Dorjbal B; Waheed S; Zahn CM; Hamilton CA; Maxwell GL; Syed V
Oncotarget; 2016 Oct; 7(43):69733-69748. PubMed ID: 27626172
[TBL] [Abstract][Full Text] [Related]
29. miR-205 promotes epithelial-mesenchymal transition by targeting AKT signaling in endometrial cancer cells.
Jin C; Liang R
J Obstet Gynaecol Res; 2015 Oct; 41(10):1653-60. PubMed ID: 26446417
[TBL] [Abstract][Full Text] [Related]
30. Curcumin exhibits anti-tumor effect and attenuates cellular migration via Slit-2 mediated down-regulation of SDF-1 and CXCR4 in endometrial adenocarcinoma cells.
Sirohi VK; Popli P; Sankhwar P; Kaushal JB; Gupta K; Manohar M; Dwivedi A
J Nutr Biochem; 2017 Jun; 44():60-70. PubMed ID: 28402926
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin Promotes Invasion, Migration and Epithelial-Mesenchymal Transition of Human Endometrial Carcinoma Cell HEC-1A Through AKT and ERK1/2 Signaling.
Li Y; Xie Y; Cui D; Ma Y; Sui L; Zhu C; Kong H; Kong Y
Cell Physiol Biochem; 2015; 37(4):1503-12. PubMed ID: 26509489
[TBL] [Abstract][Full Text] [Related]
32. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
[TBL] [Abstract][Full Text] [Related]
33. Targeting Interleukin-11 Receptor-α Impairs Human Endometrial Cancer Cell Proliferation and Invasion In Vitro and Reduces Tumor Growth and Metastasis In Vivo.
Winship AL; Van Sinderen M; Donoghue J; Rainczuk K; Dimitriadis E
Mol Cancer Ther; 2016 Apr; 15(4):720-30. PubMed ID: 26846819
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
Li LH; Zhang PR; Cai PY; Li ZC
Biomed Pharmacother; 2016 Aug; 82():161-6. PubMed ID: 27470351
[TBL] [Abstract][Full Text] [Related]
35. Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A.
Waheed S; Cheng RY; Casablanca Y; Maxwell GL; Wink DA; Syed V
Molecules; 2019 Oct; 24(20):. PubMed ID: 31623109
[TBL] [Abstract][Full Text] [Related]
36. Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinoma.
Theisen ER; Gajiwala S; Bearss J; Sorna V; Sharma S; Janat-Amsbury M
BMC Cancer; 2014 Oct; 14():752. PubMed ID: 25300887
[TBL] [Abstract][Full Text] [Related]
37. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.
Yang T; Qiu H; Bao W; Li B; Lu C; Du G; Luo X; Wang L; Wan X
PLoS One; 2013; 8(6):e67458. PubMed ID: 23840707
[TBL] [Abstract][Full Text] [Related]
39. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
[TBL] [Abstract][Full Text] [Related]
40. MiR-200a promotes epithelial-mesenchymal transition of endometrial cancer cells by negatively regulating FOXA2 expression.
Shi W; Wang X; Ruan L; Fu J; Liu F; Qu J
Pharmazie; 2017 Nov; 72(11):694-699. PubMed ID: 29442045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
